Arkolith/Insider Trading/AQST/Form 4

Boyd Peter E.

Chief People OfficerAquestive Therapeutics, Inc. (AQST) · full profile →Form 4 · filed Mar 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$124K
Net Open-Market Flow
-$124K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2026Sell(S)30K$4.17$124K339K
Mar 9, 2026Grant(A)80K—$0368K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 9, 2026Grant(A)43K$4.29$182K43K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-26-003147) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Aquestive Therapeutics, Inc.

Build

Ask your agent about AQST insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001214659-26-003147"
Ask your agent
Use Arkolith to summarize insider buying and selling at Aquestive Therapeutics, Inc.
over the last 90 days and cite the filings.